Hall Laurie J Trustee Has $4.70 Million Stake in Cigna Group $CI

Key Points

• Hall Laurie J Trustee reduced its stake in Cigna Group by 6.6%, holding $4.70 million in shares after selling 1,000 shares during the second quarter.
• Analysts have given Cigna Group a consensus rating of "Buy"** and set a price target averaging around $371.81, with multiple upgrades from firms like Barclays and TD Cowen.
• Cigna Group reported a strong earnings performance for the last quarter, with a net revenue of $67.13 billion, exceeding analyst expectations.

Hall Laurie J Trustee trimmed its position in Cigna Group (NYSE:CI - Free Report) by 6.6% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 14,223 shares of the health services provider's stock after selling 1,000 shares during the period. Cigna Group comprises approximately 1.6% of Hall Laurie J Trustee's holdings, making the stock its 21st largest holding. Hall Laurie J Trustee's holdings in Cigna Group were worth $4,702,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Modern Wealth Management LLC lifted its holdings in Cigna Group by 91.3% during the first quarter. Modern Wealth Management LLC now owns 3,130 shares of the health services provider's stock worth $1,030,000 after acquiring an additional 1,494 shares in the last quarter. Acadian Asset Management LLC lifted its stake in Cigna Group by 277.5% in the 1st quarter. Acadian Asset Management LLC now owns 8,274 shares of the health services provider's stock valued at $2,718,000 after acquiring an additional 6,082 shares in the last quarter. Dynamic Technology Lab Private Ltd acquired a new position in Cigna Group during the first quarter worth $431,000. NBC Securities Inc. bought a new stake in Cigna Group during the 1st quarter worth about $123,000. Finally, Integrity Alliance LLC. bought a new position in shares of Cigna Group in the 1st quarter valued at about $617,000. 86.99% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. TD Cowen upgraded shares of Cigna Group to a "strong-buy" rating in a report on Monday, June 23rd. Barclays lifted their target price on Cigna Group from $354.00 to $383.00 and gave the stock an "overweight" rating in a research note on Thursday, September 4th. Robert W. Baird set a $372.00 price target on Cigna Group in a report on Thursday, August 14th. Cantor Fitzgerald reissued an "overweight" rating and issued a $365.00 price objective on shares of Cigna Group in a research report on Tuesday, August 26th. Finally, Guggenheim reiterated a "buy" rating and issued a $350.00 price target (down previously from $388.00) on shares of Cigna Group in a research note on Monday, August 4th. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of $371.81.

Cigna Group Stock Down 0.5%

Shares of NYSE CI opened at $288.97 on Tuesday. The company has a market cap of $77.13 billion, a price-to-earnings ratio of 15.77, a PEG ratio of 0.85 and a beta of 0.48. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. The stock has a 50-day moving average price of $293.71 and a two-hundred day moving average price of $311.30. Cigna Group has a 12 month low of $256.89 and a 12 month high of $358.88.

Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating analysts' consensus estimates of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company had revenue of $67.13 billion during the quarter, compared to analysts' expectations of $62.61 billion. During the same period in the prior year, the company earned $6.72 EPS. Cigna Group's revenue was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 18th. Investors of record on Thursday, September 4th were given a dividend of $1.51 per share. The ex-dividend date was Thursday, September 4th. This represents a $6.04 annualized dividend and a yield of 2.1%. Cigna Group's dividend payout ratio (DPR) is currently 32.97%.

Insiders Place Their Bets

In other news, insider Nicole S. Jones sold 28,526 shares of the firm's stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the transaction, the insider owned 25,648 shares of the company's stock, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.70% of the stock is owned by insiders.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.